BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37373084)

  • 1. New Cases and Mutations in
    Musri MM; Venturi V; Ferrer-Cortès X; Romero-Cortadellas L; Hernández G; Leoz P; Ricard Andrés MP; Morado M; Fernández Valle MDC; Beneitez Pastor D; Ortuño Cabrero A; Moreno Gamiz M; Senent Peris L; Perez-Valencia AI; Pérez-Montero S; Tornador C; Sánchez M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel Mutation in the SEC23B Gene Associated With Congenital Dyserythropoietic Anemia Type II Through the Use of Next-generation Sequencing Panel in an Undiagnosed Case of Nonimmune Hereditary Hemolytic Anemia.
    Aydin Koker S; Karapinar TH; Oymak Y; Bianchi P; Fermo E; Gozmen S; Vergin C
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e421-e423. PubMed ID: 29846281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Zheng J; Gao L; Liu H; Xiao P; Lu J; Li J; Wu S; Cheng S; Bian X; Du Z; Kong L; Hu S; Fan J
    Int J Hematol; 2024 Feb; 119(2):210-214. PubMed ID: 38127226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II.
    Russo R; Langella C; Esposito MR; Gambale A; Vitiello F; Vallefuoco F; Ek T; Yang E; Iolascon A
    Blood Cells Mol Dis; 2013 Jun; 51(1):17-21. PubMed ID: 23453696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Chen S; Guo Z; Ye Y; Yang S; Huang G
    Int J Hematol; 2021 Sep; 114(3):390-394. PubMed ID: 33914262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene.
    Punzo F; Bertoli-Avella AM; Scianguetta S; Della Ragione F; Casale M; Ronzoni L; Cappellini MD; Forni G; Oostra BA; Perrotta S
    Orphanet J Rare Dis; 2011 Dec; 6():89. PubMed ID: 22208203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEC23B Loss-of-Function Suppresses Hepcidin Expression by Impairing Glycosylation Pathway in Human Hepatic Cells.
    Rosato BE; Marra R; D'Onofrio V; Del Giudice F; Della Monica S; Iolascon A; Andolfo I; Russo R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of High-Resolution Melting Curve Analysis for rapid detection of SEC23B gene mutation causing Congenital Dyserythropoietic Anemia type II in Indian population.
    Saptarshi AN; Dongerdiye RK; More TA; Kedar PS
    Ital J Pediatr; 2023 Jul; 49(1):84. PubMed ID: 37455305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene.
    Russo R; Esposito MR; Asci R; Gambale A; Perrotta S; Ramenghi U; Forni GL; Uygun V; Delaunay J; Iolascon A
    Am J Hematol; 2010 Dec; 85(12):915-20. PubMed ID: 20941788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.
    Iolascon A; Russo R; Esposito MR; Asci R; Piscopo C; Perrotta S; Fénéant-Thibault M; Garçon L; Delaunay J
    Haematologica; 2010 May; 95(5):708-15. PubMed ID: 20015893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.
    Schwarz K; Iolascon A; Verissimo F; Trede NS; Horsley W; Chen W; Paw BH; Hopfner KP; Holzmann K; Russo R; Esposito MR; Spano D; De Falco L; Heinrich K; Joggerst B; Rojewski MT; Perrotta S; Denecke J; Pannicke U; Delaunay J; Pepperkok R; Heimpel H
    Nat Genet; 2009 Aug; 41(8):936-40. PubMed ID: 19561605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
    Sharma P; Das R; Bansal D; Trehan A
    Hematology; 2015 Mar; 20(2):104-7. PubMed ID: 24801240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variant analysis of SEC23B gene in 4 families with congenital dyserythropoietic anemia].
    Feng Y; Shi P; Liu N; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):727-730. PubMed ID: 34365611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.
    Bianchi P; Fermo E; Vercellati C; Boschetti C; Barcellini W; Iurlo A; Marcello AP; Righetti PG; Zanella A
    Hum Mutat; 2009 Sep; 30(9):1292-8. PubMed ID: 19621418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of genotype and phenotype of SEC23B gene in a family affected with congenital dyserythropoietic anemia type II].
    Li D; Li B; Qu S; Cao W; Yang Y; Ma Y; Hou T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):874-878. PubMed ID: 29188620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores.
    Russo R; Gambale A; Langella C; Andolfo I; Unal S; Iolascon A
    Am J Hematol; 2014 Oct; 89(10):E169-75. PubMed ID: 25044164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E109K is a SEC23B founder mutation among Israeli Moroccan Jewish patients with congenital dyserythropoietic anemia type II.
    Amir A; Dgany O; Krasnov T; Resnitzky P; Mor-Cohen R; Bennett M; Berrebi A; Tamary H
    Acta Haematol; 2011; 125(4):202-7. PubMed ID: 21252497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.
    De Rosa G; Andolfo I; Marra R; Manna F; Rosato BE; Iolascon A; Russo R
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic features of congenital dyserythropoietic anemia (CDA).
    Moreno-Carralero MI; Horta-Herrera S; Morado-Arias M; Ricard-Andrés MP; Lemes-Castellano A; Abio-Calvete M; Cedena-Romero MT; González-Fernández FA; Llorente-González L; Periago-Peralta AM; de-la-Iglesia-Íñigo S; Méndez M; Morán-Jiménez MJ
    Eur J Haematol; 2018 Sep; 101(3):368-378. PubMed ID: 29901818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
    Kedar P; Parmar V; Devendra R; Gupta V; Warang P; Madkaikar M
    Ann Hematol; 2017 Dec; 96(12):2135-2139. PubMed ID: 28879554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.